Cancer
The latest news on cancer diagnostics, liquid biopsy, and cancer risk testing.
Kiffik Biomedical, Rubix LS Partner on Colorectal Cancer Test Development
The New England-based firms said that they are developing a rapid at-home test that will be used to detect cancer biomarkers in interstitial fluid samples.
The test can be used to better stratify cancer patients and determine the likelihood of breast cancer metastasizing.
Craig-Hallum Initiates Coverage of Veracyte With Buy Rating, $45 Price Target
The investment bank views the company as a promising target with a strong track record and prospects for expansion into new, under-penetrated markets.
Leaders from diagnostics firms and academia discussed the challenges of assessing these tests and the need for a consensus on how to bring them to the clinic.
Gestalt, Primaa Partner on AI-Based Testing for Skin Cancer
The firms said that they will integrate Primaa's skin cancer testing algorithms with Gestalt's PathFlow digital pathology software platform.